Boeh Ing sells Pharmaton business to IdeaSphere

3 September 2006

Boehringer Ingelheim, the German family-owned pharmaceutical company, says it has sold its natural health care company and business, Pharmaton SA, to IdeaSphere, a New York, USA-based company, specializing in vitamins, minerals, nutrition products and herbs. Financial terms of the transaction were not disclosed.

"IdeaSphere has been carefully selected as a result of a diligent process and will be the ideal partner to further develop Pharmaton. Boehringer Ingelheim will continue to strengthen its consumer health care business by further building up the flagship and international core brands, eg, Dulcolax, Buscopan and Antistax," said Alessandro Banchi, chairman of the board of managing directors at BI and responsible for marketing and sales. "Both Pharmaton and IdeaSphere have a common strategic vision and core competencies in the development, production and marketing of natural health and multivitamin products," Dr Banchi said, adding: "IdeaSphere's commitment supports the sustainability of the Lugano [Switzerland] site and opens future growth opportunities for its management and employees."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight